Cancers and Oncology Treatments Managed by Dr. Shekar Patil
Personalised chemotherapy for solid tumours and haematological cancers using treatment combinations selected according to cancer type, stage and individual patient factors.
Advanced systemic cancer treatment using intensive chemotherapy protocols for selected complex solid tumours and haematological malignancies.
Precision treatment using medicines designed to act on specific molecular pathways or abnormalities that contribute to cancer growth.
Modern cancer therapy designed to help the immune system recognise and attack cancer cells in appropriately selected patients.
Systemic treatment for hormone-sensitive cancers such as selected breast and prostate cancers to reduce hormone-driven tumour progression.
Comprehensive systemic therapy for early, locally advanced and metastatic breast cancer using chemotherapy, hormonal therapy, targeted therapy and immunotherapy when appropriate.
Individualised treatment of lung cancer using chemotherapy, targeted therapy and immunotherapy based on cancer subtype, molecular testing and disease stage.
Advanced medical oncology care for ovarian cancer including systemic chemotherapy and selected intraperitoneal chemotherapy approaches.
Multidisciplinary treatment of cervical cancer incorporating systemic chemotherapy and concurrent chemoradiotherapy when clinically indicated.
Specialised systemic therapy for Hodgkin and non-Hodgkin lymphomas using chemotherapy and modern targeted or immune-based therapies.
Medical oncology management of acute and selected chronic leukaemias using appropriate systemic treatment and supportive care protocols.
Comprehensive management of multiple myeloma using combination systemic therapy, targeted medicines and transplant-related planning when indicated.
Systemic treatment for cancers involving the stomach, colon, rectum, pancreas and other gastrointestinal organs using personalised oncology protocols.
Medical oncology management of head and neck malignancies using chemotherapy, targeted therapy, immunotherapy and concurrent chemoradiation where appropriate.
Personalised cancer treatment using tumour characteristics, biomarkers and molecular information to identify suitable targeted and novel therapies.